56 research outputs found
Anomaly in the dielectric response at the charge orbital ordering transition of crystalline Pr0.67Ca0.33MnO3
The complex impedance of a Pr0.67Ca0.33MnO3 crystal has been measured. The
frequency dependence is studied for a wide range of temperatures (50K-403K) and
is found to be characteristic of relaxation process with a single Debye time
relaxation constant, which is interpreted as a dielectric constant of the
material. A strong peak is observed in this dielectric constant (up to two
millions) at the charge ordering transition suggesting an interpretation in
terms of ordering of electric dipoles at TCO or in term of phase separation.
Comparison with Pr0.63Ca0.37MnO3 - in which the phase separation is much
smaller and the peak in the dielectric constant is absent - suggests an
interpretation in term of phase separation between insulating and metallic
states.Comment: pdf fil
Effets d’une attaque de tordeuse des bourgeons de l’épinette sur l’exportation d’éléments au-dessous de la zone racinaire : une étude de cas dans une forêt de sapins baumiers
Fréquence des troubles organiques chez les patients admis pour un motif psychiatrique aux urgences
Évaluation de l’efficacité spécifique en population infanto-juvénile d’un dispositif de veille et de recontact (VigilanS) en termes de prévention de la réitération suicidaire
Comprehensive mapping of immune tolerance yields a regulatory TNF receptor 2 signature in a murine model of successful Fel d 1-specific immunotherapy using high-dose CpG adjuvant.
Background: The prevalence of allergy to cat is expanding worldwide. Allergen-specific immunotherapy (AIT) has advantages over symptomatic pharmacotherapy and promises long-lasting disease control in allergic patients. However, there is still a need to improve cat AIT regarding efficacy, safety, and adherence to the treatment. Here, we aim to boost immune tolerance to the major cat allergen Fel d 1 by increasing the anti-inflammatory activity of AIT with the established immunomodulatory adjuvant CpG, but at a higher dose than previously used in AIT. Methods: Together with CpG, we used endotoxin-free Fel d 1 as therapeutic allergen throughout the study in a BALB/c model of allergy to Fel d 1, thus mimicking the conditions of human AIT trials. Multidimensional immune phenotyping including mass cytometry (CyTOF) was applied to analyze AIT-specific immune signatures. Results: We show that AIT with high-dose CpG in combination with endotoxin-free Fel d 1 reverts all major hallmarks of allergy. High-dimensional CyTOF analysis of the immune cell signatures initiating and sustaining the AIT effect indicates the simultaneous engagement of both, the pDC-Treg and B-cell axis, with the emergence of a systemic GATA3+ FoxP3hi biTreg population. The regulatory immune signature also suggests the involvement of the anti-inflammatory TNF/TNFR2 signaling cascade in NK and B cells at an early stage and in Tregs later during AIT. Conclusion: Our results highlight the potential of CpG adjuvant in a novel formulation to be further exploited for inducing allergen-specific tolerance in patients with cat allergy or other allergic diseases
Gastric antral vascular ectasia syndrome : clinical and endoscopic presentation and endoscopic treatment
Nous rapportons une série de dix patients chez lesquels un «syndrome d'Ectasies Vasculaires Antrales » a été découvert lors d'un bilan endoscopique. Sept patients présentaient une anémie ferriprive chronique et ont bénéficié d'un traitement endoscopique. Les aspects clinique, physiopathologique, histologique et endoscopique sont discutés à la lumière de la littérature
Predictive value of CDKN2A/p16INK4a expression in the malignant transformation of oral potentially malignant disorders: Systematic review and meta-analysis
Background: Management of oral potentially malignant disorders (OPMDs) is still challenging. Despite the diagnostic ascertainment by bioptic examination, this method is poorly informative of the prognosis and subsequent malignant transformation. Prognosis is based on histological findings by grading of dysplasia. Immunohistochemical expression of p16INK4a has been investigated in different studies, with controversial results. In this scenario, we systematically revised the current evidence about p16INK4a immunohistochemical expression and the risk of malignization of OPMDs. Material and methods: After a proper set of keywords combination, 5 databases were accessed and screened to select eligible studies. The protocol was previously registered on PROSPERO (Protocol ID: CRD42022355931). Data were obtained directly from the primary studies as a measure to determine the relationship between CDKN2A/P16INK4a expression and the malignant transformation of OPMDs. Heterogeneity and publication bias were investigated by different tools, such as Cochran's Q test, Galbraith plot and Egger and Begg Mazumdar's rank tests. Results: Meta-analysis revealed a twofold increased risk to malignant development (RR = 2.01, 95% CI = 1.36–2.96 - I2 = 0%). Subgroup analysis did not highlight any relevant heterogeneity. Galbraith plot showed that no individual study could be considered as an important outlier. Conclusion: Pooled analysis showed that p16INK4a assessment may arise adjunct tool to dysplasia grading, leading to an optimized determination of the potential progression to cancer of OPMDs. The p16INK4a overexpression analysis by immunohistochemistry techniques has a multitude of virtues that may facilitate its incorporation in the day-to-day prognostic study of OPMDs
- …
